Clinical Trial: Efficacy, Safety, and Tolerability of PF-06823859 in Patients With Dermatomyositis

IRB: IRB00144439

Purpose of Study: Recruitment is underway in Baltimore and other sites for a research study of an investigational medicine for dermatomyositis (DM). This study will assess the effectiveness and safety of a Study drug compared to placebo. The study drug is a type of drug called a biologic and is given monthly by injection into your vein.

Eligibility Criteria:

Study volunteers must meet the following criteria: To be eligible for this trial, a patient must:

• Be 18 to 75 years of age
• Have a diagnosis of DM
• Have active DM-related skin disease
• Failed to respond to at least 1 standard of care systemic treatment like corticosteroids
• Must be willing to undergo skin biopsies
• Willing to come in for 10 on-site visits over 8 months

Go to ClinicalTrials.gov where you will find information on the trial recruitment status, eligibility, locations, and contact details. ClinicalTrials.gov Identifier: NCT03181893

Study Status:

Recruiting

ClinicalTrials.gov Link:

Visit ClinicalTrials.gov

Specialty Center:

Myositis Center

Principal Investigator: